Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)
China · Delayed Price · Currency is CNY 5.66
-0.17 (-2.92%)
Aug 21, 2026, 3:04 PM CST
SHE:002370 Revenue
Zhejiang Yatai Pharmaceutical had revenue of 59.58M CNY in the quarter ending March 31, 2026, a decrease of -7.71%. This brings the company's revenue in the last twelve months to 318.16M, down -10.88% year-over-year. In the year 2025, Zhejiang Yatai Pharmaceutical had annual revenue of 323.14M, down -20.25%.
Revenue (ttm)
318.16M
Revenue Growth
-10.88%
P/S Ratio
13.27
Revenue / Employee
622.63K
Employees
511
Market Cap
4.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 323.14M | -82.04M | -20.25% |
| Dec 31, 2024 | 405.17M | -15.47M | -3.68% |
| Dec 31, 2023 | 420.64M | 47.20M | 12.64% |
| Jan 1, 2023 | 373.44M | 58.31M | 18.50% |
| Jan 1, 2022 | 315.13M | -199.75M | -38.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 25.24B |
| Jinling Pharmaceutical Company | 3.16B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.78B |
| LanZhou Foci Pharmaceutical | 926.49M |
| Harbin Medisan Pharmaceutical | 813.23M |
| Nanjing Hicin Pharmaceutical | 688.74M |
| Newland Pharmaceutical | 659.54M |
| Zhongzhu Healthcare Holding Co.,Ltd | 544.73M |